Trials / Completed
CompletedNCT03731286
A Long-term Safety and Efficacy of EnXtra (E-AG-01) in Healthy Adults
A Double-Blind Randomized, Double-dummy, Placebo-controlled, Parallel-Group Study of the Long-term Safety and Efficacy of EnXtra (E-AG-01) in Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The present study has been proposed to investigate the long-term safety and efficacy of EnXtra in healthy adults habituated to caffeine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Alpinia Galanga | 2 capsules |
| DIETARY_SUPPLEMENT | Alpinia Galanga | 2 capsules |
| DIETARY_SUPPLEMENT | Microcellulose crystalline | 2 capsules |
Timeline
- Start date
- 2018-11-23
- Primary completion
- 2019-08-30
- Completion
- 2019-12-30
- First posted
- 2018-11-06
- Last updated
- 2021-03-11
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03731286. Inclusion in this directory is not an endorsement.